l e t t e r s Exome sequencing has become a powerful and effective strategy for the discovery of genes underlying Mendelian disorders 1 . However, use of exome sequencing to identify variants associated with complex traits has been more challenging, partly because the sample sizes needed for adequate power may be very large 2 . One strategy to increase efficiency is to sequence individuals who are at both ends of a phenotype distribution (those with extreme phenotypes). Because the frequency of alleles that contribute to the trait are enriched in one or both phenotype extremes, a modest sample size can potentially be used to identify novel candidate genes and/or alleles 3 . As part of the National Heart, Lung, and Blood Institute (NHLBI) Exome Sequencing Project (ESP), we used an extreme phenotype study design to discover that variants in DCTN4, encoding a dynactin protein, are associated with time to first P. aeruginosa airway infection, chronic P. aeruginosa infection and mucoid P. aeruginosa in individuals with cystic fibrosis.
l e t t e r s Exome sequencing has become a powerful and effective strategy for the discovery of genes underlying Mendelian disorders 1 . However, use of exome sequencing to identify variants associated with complex traits has been more challenging, partly because the sample sizes needed for adequate power may be very large 2 . One strategy to increase efficiency is to sequence individuals who are at both ends of a phenotype distribution (those with extreme phenotypes). Because the frequency of alleles that contribute to the trait are enriched in one or both phenotype extremes, a modest sample size can potentially be used to identify novel candidate genes and/or alleles 3 . As part of the National Heart, Lung, and Blood Institute (NHLBI) Exome Sequencing Project (ESP), we used an extreme phenotype study design to discover that variants in DCTN4, encoding a dynactin protein, are associated with time to first P. aeruginosa airway infection, chronic P. aeruginosa infection and mucoid P. aeruginosa in individuals with cystic fibrosis.
For unknown reasons, individuals with cystic fibrosis (MIM 219700) are at high risk for P. aeruginosa infection, and the airways of ~80% of adult individuals with cystic fibrosis are infected 4 . P. aeruginosa acquisition is associated with worse long-term pulmonary disease and survival 5 , and chronic P. aeruginosa infection is associated with reduced lung function, faster rate of lung function decline, increased exacerbation of disease and shorter median survival 6, 7 . Accordingly, early eradication regimens for initial P. aeruginosa infection and aggressive treatment of chronic P. aeruginosa infection are standard of care 8 . Discovery of host factors that influence risk of P. aeruginosa airway infection could help identify mechanisms for increased susceptibility to P. aeruginosa infection in cystic fibrosis and define subpopulations for aggressive screening and therapy.
We successfully performed exome sequencing of 91 of 96 individuals selected for sequencing from the Early Pseudomonas Infection Control (EPIC) 8 Observational Study and the North American cystic fibrosis Genetic Modifiers Study (GMS) 9 to identify factors leading to P. aeruginosa infection in cystic fibrosis (Online Methods and Supplementary Table 1 ). Forty-three individuals with early age of onset of chronic P. aeruginosa infection (early P. aeruginosa extreme, all below the 10th percentile of age of onset) and the 48 oldest individuals who had not reached chronic P. aeruginosa infection (late P. aeruginosa extreme, all past the median age of onset) were sequenced (Online Methods and Supplementary Note). Percentiles were estimated from a distribution of 1,322 EPIC individuals. Successfully sequenced individuals in the early P. aeruginosa extreme sample had at least two consecutive quarters (3-month periods) with positive cultures for P. aeruginosa before 5 years of age (EPIC, n = 38) or had at least 10 consecutive years of positive cultures for P. aeruginosa, starting at age 1, and no more than one P. aeruginosa-negative culture (GMS, n = 5). The late P. aeruginosa extreme sample consisted of individuals who had never had P. aeruginosa infection by age 14 (EPIC, n = 38) and individuals who were P. aeruginosa free to age 20 or beyond (GMS, n = 10). The early P. aeruginosa extreme sample had a 400-fold higher frequency of P. aeruginosa-positive cultures compared to the late P. aeruginosa extreme sample (Supplementary Note).
Logistic regression was performed to test for association between phenotype group and variant scores collapsed by gene using the RVT1 method 10 . We initially included variants with an empirical minor allele frequency (MAF) of ≤0.125 in the collapsed gene scores to l e t t e r s avoid eliminating causal variants enriched to high frequency and to allow for sampling variability, resulting in the identification of 11,542 genes in which at least one person had a variant and for which the distribution of variants was not collinear with the risk group variable (Supplementary Note). The model was adjusted for ancestry, using scores for three principal components from the principal-component decomposition of the exome data, and for CFTR mutation risk group, by including a score that was based on whether individuals were in risk group 1 or not 11 (Online Methods, Supplementary Table 2 and Supplementary Note).
After Bonferroni adjustment, a single gene, DCTN4 (encoding dynactin 4) on chromosome 5q33.1, was significantly associated with time to chronic P. aeruginosa infection (naïve P = 2.2 × 10 −6 ; adjusted P = 0.025; Supplementary Fig. 1 ). This result remained unchanged when the analysis was limited to variants with empirical MAF of ≤0.05 ( Fig. 1a) and was robust across multiple analytical methods ( Supplementary  Figs. 2 and 3 and Supplementary Note). A resampling-based P value of 1.5 × 10 −6 was obtained from 10 million parametric bootstrap trials of the RVT1 test under the null hypothesis of equal proportions of individuals with DCTN4 variants in each study arm. The resulting quantilequantile plot showed no deviations from expected behavior that could have led to a spurious P value for DCTN4 ( Supplementary Fig. 4) .
Inspection of the exome sequencing data for DCTN4 revealed that 12 of the 43 individuals in the early P. aeruginosa extreme sample had a missense variant in DCTN4; 9 were heterozygous at position 150,097,883 (rs11954652; encoding p.Phe349Leu; MAF = 0.048 in European Americans according to the NHLBI Exome Variant Server (EVS)) and 3 at position 150,110,239 (rs35772018; encoding p.Tyr270Cys; MAF = 0.017 in European Americans according to EVS). Linkage disequilibrium (LD) between these variants was low, and both variants occurred at highly conserved sites (Genetic Evolutionary Rate Profiling scores of 4.1 and 5.4, respectively). None of the 48 individuals in the late P. aeruginosa extreme sample had missense variants in DCTN4.
On the basis of these findings, we screened DCTN4 by Sanger sequencing in 1,322 EPIC participants and selected for validation analysis all participants who were enrolled under the criterion of no previous P. aeruginosa-positive cultures, excluding individuals in the exome sequencing study (Online Methods and Supplementary Note). The validation set of 696 individuals with varied CFTR genotypes had a median of 22 quarters of P. aeruginosa culture observations per subject (16,754 quarters total; Supplementary Table 3 ). Among the validation set, 78 participants were heterozygous and 9 were homozygous for the non-reference allele (C) at rs11954652, 15 were heterozygous for rs35772018 (2 of whom were not called at rs11954652) and 27 individuals were not called at either site. One individual was heterozygous for both missense variants. Three remaining individuals carried other missense variants, which were explored in secondary analyses (Supplementary Note).
We then assessed whether genotype at either rs11954652 or rs35772018 predicted age of first P. aeruginosa-positive culture and/or age of onset of chronic P. aeruginosa infection in the validation set, using the same definition of chronic P. aeruginosa infection as in the exome study. Because individuals who were enrolled at older ages were selected for a P. aeruginosa-negative history, we performed a Cox regression analysis stratified on enrollment age (individuals enrolled at later ages with a P. aeruginosa-negative history were not at risk before enrollment), adjusting for CFTR risk group, number of culture quarters on study and enrollment age (Online Methods and Supplementary Note).
The presence of at least one DCTN4 missense variant was significantly associated with both early age of first P. aeruginosa-positive culture (P = 0.01, hazard ratio (HR) = 1.4; Table 1 and Supplementary  Fig. 5 ) and with early age at onset of chronic P. aeruginosa infection (P = 0.004, HR = 1.9; Fig. 1b and Table 1 ). The risk was highest in individuals with less selective bias toward a P. aeruginosa-negative history (children enrolled before 1.5 years of age and 103 enrollees who participated in the study despite a history of P. aeruginosa-positive cultures) (P = 0.004, HR = 2.7; Fig. 1c and Supplementary Figs. 6 and 7) . A stronger effect at younger ages is generally expected in this cohort, as individuals who never had P. aeruginosa before older enrollment ages represent a group more highly enriched for resistance factors. . Individuals in the latter group have higher risk than those in either of the other two groups (HR = 3.3, P = 0.002 compared to baseline). Differences between groups appear somewhat compressed relative to the Cox model HR estimates because all enrollment strata are shown together: there are too few individuals in the third group to visualize differences within strata, but it is notable that a strong difference can be seen even without stratification.
npg l e t t e r s No significant interaction was found between CFTR genotypes and DCTN4 mutations, although power to detect such an interaction was low (Supplementary Note).
Because rs11954652[C] is common in African Americans (MAF = 0.53 according to EVS), we repeated the analysis using only selfidentified European Americans (n = 645) with a similar result (P = 0.03, HR = 1.7) ( Supplementary Figs. 8 and 9) . Additionally, for 530 individuals for whom genome-wide genotyping data were available, we repeated the analysis using principal-component decomposition to exclude all those with non-European ancestry (Supplementary Figs. 10  and 11) , again with the same result (P = 0.004, HR = 2.2). These analyses confirm that effects from genetic ancestry did not confound our results. We also found a relationship between risk for P. aeruginosa infection and burden or rarity/conservation of variants. When individuals with DCTN4 mutations were subdivided by burden and the specific site of mutation, those who were homozygous for the more common variant (n = 9) or heterozygous for the rarer and more highly conserved site (n = 13) had the higher risk for early-onset P. aeruginosa infection compared to individuals with neither variant (HR = 3.3, P = 0.002; Fig. 1d and Table 1 ) and compared to individuals heterozygous for the more common variant (HR = 2.7, P = 0.01). When individuals with the rarer rs35772018 variant were analyzed as a group by themselves, the HR for age of onset of chronic P. aeruginosa infection associated with rs35772018 genotype was estimated to be 15.9 at birth (P = 0.002) relative to individuals with neither variant (Supplementary Figs. 12-14 and Supplementary Tables 4 and 5) . Notably, estimates from analysis using evidence of 50% of cultures that were positive for P. aeruginosa infection in any 1-year period to define chronic P. aeruginosa infection (not necessarily consecutive positive cultures), analogous to the widely accepted Leeds criterion 12 , were similar but more significant (Supplementary Figs. 6, 7, 9, 13 and 14 , Supplementary Table 5 and Supplementary Note.)
Transformation of P. aeruginosa to the mucoid state is an adaptation of P. aeruginosa to the host environment and is associated with rapid progression of cystic fibrosis airway disease 13 . Carriage of either DCTN4 variant was also significantly associated with age of onset of the first mucoid P. aeruginosa culture, with the effect again stronger in younger enrollees, with an estimated HR = 2.6 at birth (P = 0.03; Table 1 and Supplementary Fig. 15 ). Additionally, the interval between first P. aeruginosa-positive culture and first mucoid P. aeruginosa culture was significantly shorter in individuals with DCTN4 variants (HR = 3.8, P = 0.01). Analysis of a second auxiliary outcome, frequency of P. aeruginosa-positive cultures over the study period, showed that individuals with DCTN4 missense variants had higher rates of P. aeruginosa positivity (P = 0.02) (Supplementary Fig. 16 ). Because we excluded study subjects who underwent exome sequencing from the validation analysis, the P values from the validation study are independent of the P value estimated from the exome sequencing data. These results support a strong association between the presence of DCTN4 missense variants and susceptibility to both earlier and more severe P. aeruginosa infection.
Dynactin 4 is a component of the dyneindependent motor that moves autophagosomes along microtubules into lysosomes for degradation as part of the autophagy process-a highly conserved cellular quality control mechanism to transport and degrade damaged proteins and microbes 14, 15 . P. aeruginosa induces autophagy in alveolar macrophages in vitro, and autophagy has an essential role in the clearance of P. aeruginosa 16 . In cystic fibrosis, intracellular accumulation of CFTR∆F508 is associated with reduced macroautophagic flux via inhibition of autophagosome formation. This results in increased airway inflammation 15 . It is possible that isoforms of dynactin 4 influence P. aeruginosa infection in cystic fibrosis by reducing autophagic clearance of P. aeruginosa in the airway of individuals with cystic fibrosis or by altering macroautophagic clearance of class II mutant CFTR (for example, ∆F508), leading to increased airway disease.
To our knowledge, this is the first study to discover a gene for a complex trait, or at minimum a genetic modifier of a Mendelian trait, using exome sequencing and an extreme phenotype study design. Notably, given the sample size of EPIC and the low frequency of rs11954652 and rs35772018 alleles, neither would have achieved genome-wide significance via genome-wide association study (GWAS), and neither variant is on common SNP-genotyping platforms or is tagged well (Supplementary Note). Our success with exome sequencing was due, in part, to the synergy of several key factors, including the use of phenotypically well-matched extremes with the exception of the trait of interest, a relatively large estimated effect size for DCTN4 and a reasonably high collective MAF for implicated variants (0.065), with the higher MAF variants intentionally included in our analyses. In most cases, use of a similar strategy to find variants underlying complex traits will likely require exome sequencing of larger sample sizes. However, we think that enthusiasm for this approach should continue as the cost of sequencing is dropping rapidly and more efficient statistical approaches for analysis of rare variants are becoming available. 
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Methods and any associated references are available in the online version of the paper.
Accession codes. Exome data are available at the NCBI dbGaP repository under accession phs000254.v1.p1.
Note: Supplementary information is available in the online version of the paper.
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Library production and exome capture. Approximately 3.5 µg of genomic DNA was used for a series of shotgun library construction steps, including acoustic fragmentation (Covaris), end-polishing and A-tailing, ligation of sequencing adaptors and PCR amplification. Sample shotgun libraries were captured for exome enrichment using one of three in-solution capture products: CCDS 2008 (~26 Mb), Roche/Nimblegen SeqCap EZ Human Exome Library v1.0 (~32 Mb; Roche Nimblegen EZ Cap v1) or EZ Cap v2 (~34 Mb) per the manufacturer's instructions.
Clustering and sequencing. Library concentration and flow-cell loading cluster densities were determined using a standardized quantitative PCR (qPCR) protocol (Kapa Biosystems). Using the automated Illumina cBot cluster station, non-multiplexed samples were processed in batches of eight (one for each lane of the flow cell) and were diluted and denatured to their final effective loading concentrations. Hybridization was followed by cluster generation via bridge PCR according to standard protocols (Illumina). Enriched libraries were sequenced on an Illumina Genome Analyzer IIx using paired-end 76-base runs.
Read mapping and variant analysis. Samples were processed in real-time basecalls (RTA 1.7 software (Bustard), converted to qseq.txt files and aligned to a human reference genome (hg19) using Burrows-Wheeler Aligner (BWA) 18 . Read pairs not mapping within 2 s.d. of the average library size (~125 ± 15 bp for exomes) were removed. Data were processed using the Genome Analysis ToolKit (GATK refv1.2905) 19 . All aligned read data were subjected to removal of reads with duplicate start positions, indel realignment and base-quality recalibration. Variant detection and genotyping were performed using the UnifiedGenotyper tool from GATK and were only performed on the targeted exome regions. Variant data for each sample were formatted (variant call format (VCF)) as 'raw' calls for all samples, and sites were flagged if they had lower quality or were false positives (those with low quality scores (≤50), allelic imbalance (≥0.75), long homopolymer runs (>3) and/or low quality by depth (<5)). Samples were considered complete when exome-targeted read coverage was >8× over >90% of the exome target. Typical mean coverage of the target was 60-80×.
Data analysis quality control. Individual exome sequencing data were evaluated against quality control metrics (Supplementary Table 1) , including assessment of (i) total reads: a minimum of 30 million paired-end reads;
(ii) library complexity: the ratio of unique reads to total reads mapped to the target; (iii) capture efficiency: the ratio of reads mapped to the target versus the reads mapped to the human reference; (iv) coverage distribution: 90% at ≥8× required for completion; (v) capture uniformity; (vi) raw error rates; (vii) transition/transversion (Ti/Tv) ratio (3.2 for known sites and 2.9 for novel sites); (viii) distribution of known and novel variants relative to dbSNP; (ix) fingerprint concordance of >99%; (x) homozygosity; and (xi) heterozygosity. All quality control metrics for both single-lane and merged data were reviewed to identify data deviations from known or historical norms. Lanes and/or samples that failed quality control were requeued for library preparation or further sequencing. Variant sites were excluded from analyses if they had >10% missingness, failed Hardy-Weinberg equilibrium (P < 0.005/N) or if they had Qual of <30, QD of <5, AB of <0.25 or AB of >0.75 ( Supplementary  Table 1 ). No DCTN4 sites for any individuals were removed due to low quality.
Statistical analysis.
Selection of phenotypic extremes. The definition of chronic P. aeruginosa infection-two consecutive 3-month periods with a P. aeruginosapositive culture within each period-was chosen to be concordant with the definition used in the EPIC clinical trial to mark P. aeruginosa not eradicated by treatment 8 . We determined that individuals had reached the chronic endpoint if they had a 6-month period of positive cultures. This definition is also very similar to the Leeds criterion 12 . Individuals in the analysis set had a median of 3.5 culture quarters per year.
Selection of extreme individuals. Of the 38 EPIC individuals with earlyonset chronic P. aeruginosa infection in the exome sequencing sample, half were in the earliest 5% overall (≤2.5 years of age at onset), and all were in the earliest 7% (≤5 years of age) (as estimated by Kaplan-Meier curve using the 1,322 participants from the EPIC DNA Collection study). These individuals represent the extreme in terms of overall frequency of P. aeruginosa-positive quarters, with all being in the worst 20% and half among the worst 4% (>24% of quarters positive). These 38 individuals had a total of 1,165 quarters of observation time, with 334 of these quarters positive for P. aeruginosa (28%). The five GMS individuals selected for the early-onset P. aeruginosa extreme phenotype had contiguous years with positive cultures from the first or second year of life until the end of follow-up analysis (minimum follow-up age = 12, maximum = 19), with the exception of two individuals, who each had 1 year without positive cultures. EPIC individuals for the late-onset extreme (n = 38 successful exomes) were selected from among the oldest individuals who were still P. aeruginosa free at the time of selection of the exome sequencing sample. A sample of individuals who had never had P. aeruginosa infection was chosen to balance the early-onset chronic sample in terms of sex and CFTR clinical risk group (1, 2 or unknown), although most individuals were in risk group 1 (35 in the early-onset extreme and 37 in the late-onset extreme for successful exomes) 11 . The ten individuals selected for the late-onset extreme from GMS were P. aeruginosa free until at least age 20, with one individual P. aeruginosa free until age 58. All GMS participants were in CFTR risk group 1.
Two-sample test by gene for exome data. A previously described method 10 was used to obtain P values for each gene. We adjusted each gene test for CFTR risk group (risk group 1 or not) and for PC1, PC2 and PC18 from a principal-component decomposition of the entire set of exome data, after applying quality control filters ( Supplementary Table 2 ). Indicators for sex and siblings were initially entered but were discarded after the empirical distributions of covariates for these variables were found to center at zero. The first two principal components were included in the regression model to adjust for possible ancestry-related stratification. PC18 was added to the model after examining box plots of PC3 through PC20 for cases versus controls, as PC18 showed a relatively large difference between the two groups.
Resampling-based estimation of P value. The nominal P value for DCTN4 from the RVT1 test, as well as the general performance of the test for the specific data and sample size, was assessed via a parametric bootstrap. The parametric bootstrap was performed by drawing non-reference alleles for each person according to the joint binomial distributions for the two variants, on the basis of ESP-wide observed MAFs and correlation (rs11954652: MAF = 0.048; rs35772018: MAF = 0.0178). Alleles were drawn independently for each person under the null hypothesis of no association with phenotype group. The RVT1 test was then performed using these random variants to form gene scores, while keeping each person's covariates and phenotype group fixed. We performed 10 million trials of this bootstrap procedure to obtain a precise estimate of the P value and to examine the behavior of the RVT1 test statistics in the tail of the distribution (Supplementary Fig. 4) .
Cox model analyses. Censored data methods (Cox model and Kaplan-Meier survival curves) were used to determine that hazard ratio for time to event for participants with either of the DCTN4 variants versus those without either. Events studied were age at onset of chronic P. aeruginosa infection, age at onset of first P. aeruginosa-positive culture, age at onset of mucoid P. aeruginosa and time between first P. aeruginosa and first mucoid P. aeruginosa culture (excluding zero times). Additional analyses were carried out using separate indicators for participants who were heterozygous at the rs11954652 locus, homozygous at the rs11954652 locus and heterozygous at the rs35772018 locus. Because of the small numbers of events in the latter two groups npg
